Crescent Biopharma logo

Crescent Biopharma Share Price (NASDAQ: CBIO)

$13.9

-0.03

(-0.22%)

Live

Last updated on

Check the interactive Crescent Biopharma Stock chart to analyse performance

Crescent Biopharma stock performance

as on August 16, 2025 at 12:36 AM IST

  • Today's Low:$13.89
    Today's High:$14.01

    Day's Volatility :0.86%

  • 52 Weeks Low:$10.83
    52 Weeks High:$21.40

    52 Weeks Volatility :49.39%

Crescent Biopharma Stock Returns

PeriodCrescent Biopharma IncIndex (Russel 2000)
3 Months
5527.53%
0.0%
6 Months
4693.1%
0.0%
1 Year
7656.7%
0.0%
3 Years
-50.97%
-12.5%

Crescent Biopharma Inc Key Stats

Check Crescent Biopharma key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$13.93
Open
$13.9
Today's High
$14.01
Today's Low
$13.89
Market Capitalization
$292.5M
Today's Volume
$56.6K
52 Week High
$21.4
52 Week Low
$10.83
Revenue TTM
$0.0
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
0.0%

Stock Returns calculator for Crescent Biopharma Stock including INR - Dollar returns

The Crescent Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Crescent Biopharma investment value today

Current value as on today

₹77,26,477

Returns

₹76,26,477

(+7.63K%)

Returns from Crescent Biopharma Stock

₹76,22,222 (+7.62K%)

Dollar Returns*

₹4,255 (+4.26%)

Indian investors sentiment towards Crescent Biopharma Stock

-83%

Period: Jul 15, 2025 to Aug 14, 2025. Change in 30 Days versus previous period

Search interest for Crescent Biopharma Stock from India on INDmoney has decreased by -83% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Crescent Biopharma Inc

  • Name

    Holdings %

Analyst Recommendation on Crescent Biopharma Stock

Rating
Trend

Crescent Biopharma Share Price Target

What analysts predicted

Upside of 58.27%

Target:

$22.00

Current:

$13.90

Crescent Biopharma share price target is $22.00, a slight Upside of 58.27% compared to current price of $13.90 as per analysts' prediction.

Crescent Biopharma Stock Insights

  • Price Movement

    In the last 3 months, CBIO stock has moved up by 5464.5%
  • CBIO vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 91.6% return, outperforming this stock by 143.6%

Crescent Biopharma Technicals Summary

Sell

Neutral

Buy

Crescent Biopharma is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Crescent Biopharma Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Crescent Biopharma Inc logo
5.78%
4693.1%
7656.7%
-50.97%
-83.18%
Regeneron Pharmaceuticals, Inc. logo
3.34%
-15.94%
-51.82%
-12.71%
-8.78%
Beone Medicines Ltd logo
10.04%
33.07%
60.93%
63.19%
37.46%
Vertex Pharmaceuticals Incorporated logo
-16.76%
-14.85%
-17.19%
28.99%
42.73%
Alnylam Pharmaceuticals, Inc. logo
37.12%
72.6%
68.49%
94.01%
214.59%

About Crescent Biopharma Inc

Crescent Biopharma, Inc., an oncology company, develops therapies for cancer patients. Its pipeline includes a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates to treat solid tumors. The company is headquartered in Waltham, Massachusetts.
Organization
Crescent Biopharma
Employees
33
CEO
Mr. Joshua T. Brumm
Industry
Miscellaneous

Key Management of Crescent Biopharma Inc

NameTitle
Mr. Joshua T. Brumm
CEO & Director
Dr. Jonathan McNeill M.D.
President & COO
Mr. Richard William Scalzo M.B.A.
Chief Financial Officer
Mr. Ryan Lynch
Senior VP of Finance, Treasurer & Chief Accounting Officer
Dr. Jan Pinkas Ph.D.
Chief Scientific Officer
Ms. Barbara H. Bispham J.D.
General Counsel & Corporate Secretary
Ms. Amy Reilly
Chief Communications Officer
Mr. Christopher Doughty
Chief Business Officer
Dr. Wenjie Cheng Ph.D.
Senior Vice President of Technical Operations
Dr. Ellie Im M.D.
Chief Medical Officer

Important FAQs about investing in CBIO Stock from India :

What is Crescent Biopharma share price today?

Crescent Biopharma share price today is $13.90 as on . Crescent Biopharma share today touched a day high of $14.01 and a low of $13.89.

What is the 52 week high and 52 week low for Crescent Biopharma share?

Crescent Biopharma share touched a 52 week high of $21.40 and a 52 week low of $10.83. Crescent Biopharma stock price today, is trending at $13.90, lower by 35.05% versus the 52 week high.

How to invest in Crescent Biopharma Stock (CBIO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Crescent Biopharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Crescent Biopharma Shares that will get you 0.1079 shares as per Crescent Biopharma share price of $13.90 per share as on August 16, 2025 at 12:36 AM IST.

What is the minimum amount required to buy Crescent Biopharma Stock (CBIO) from India?

Indian investors can start investing in Crescent Biopharma (CBIO) shares with as little as ₹87.492 or $1 (as of August 15, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹874.92 in Crescent Biopharma stock (as per the Rupee-Dollar exchange rate as on August 15, 2025). Based on Crescent Biopharma share’s latest price of $13.90 as on August 16, 2025 at 12:36 AM IST, you will get 0.7194 shares of Crescent Biopharma. Learn more about fractional shares .

What are the returns that Crescent Biopharma has given to Indian investors in the last 5 years?

Crescent Biopharma stock has given -83.18% share price returns and 16.81% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?